Chemical Compound
Doxazosin impurity H
CAS Registry Number
102839-00-9
Primary Record
Doxazosin impurity H
- In stock
- 5,569 g
- Purity
- 99.6 %
- CAS
- 102839-00-9
Compound Identifiers & Properties
- CAS
- 102839-00-9
- PubChem CID
- 616293
- SMILES
- COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C4=NC5=CC(=C(C=C5C(=N4)N)OC)OC)N)OC
- Canonical SMILES
- COc1cc2nc(N3CCN(c4nc(N)c5cc(OC)c(OC)cc5n4)CC3)nc(N)c2cc1OC
Names & Synonyms
- Doxazosin impurity H
- 102839-00-9
- Terazosin EP Impurity E
- Terazosin impurity E
- UNII-GZ7F9EWD85
- AC1LDCYD
- (Terazosin Impurity)"
- GZ7F9EWD85
- Terazosin dimer impurity
- Prazosin EP Impurity E
- RefChem:73128
- Terazosin impurity E CRS
- Oprea1_697601
- Doxazosin mesilate impurity H
- Doxazosin mesilate impurity H [EP]
- DTXSID50145536
- TCMDC-123865
- GNF-Pf-3195
- AMY192
- CHEMBL546591
- 1,4-Bis(4-amino-6,7-dimethoxy-2-quinazolinyl)piperazine
- 2,2'-(Piperazine-1,4-diyl)bis(6,7-dimethoxyquinazolin-4-amine)
- DTXCID5068027
- SCHEMBL31187488
- TCMDC 123865
- XJWKWPCORQUMQI-UHFFFAOYSA-N
- 2,2'-(1,4-Piperazinediyl)bis[6,7-dimethoxy-4-quinazolinamine]
- C24H28N8O4
- ZINC721858
- CID616293
- MFCD00844357
- STK768256
- Terazosin EP Impurity E (free base)
- AKOS001734181
- IP27062
- ST039259
- TERAZOSIN RELATED COMPOUND C FREE BASE
- 2-[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine
- FT-0673924
- DOXAZOSIN MESILATE IMPURITY H [EP IMPURITY]
- 4-Quinazolinamine, 2,2'-(1,4-piperazinediyl)bis(6,7-dimethoxy-
- C10988
- PRAZOSIN HYDROCHLORIDE IMPURITY E [EP IMPURITY]
- A898857
- SR-01000538610
- A2800/0118358
- DOXAZOSIN MESILATE IMPURITY H (EP IMPURITY)
- SR-01000538610-1
- PRAZOSIN HYDROCHLORIDE IMPURITY E (EP IMPURITY)
- Q27279368
- 2,2/'-(1,4-Piperazinediyl)bis[6,7-diMethoxy-4-quinazolinaMine]
- TERAZOSIN HYDROCHLORIDE DIHYDRATE IMPURITY E [EP IMPURITY]
- 1,4-Bis-(4-amino-6,7-dimethoxy-2-quinazolinyl)piperazine
- 2,2'-(1,4-Piperazinediyl)bis[6,7-dimethoxy-4-quinazolinamine](Terazosin Impurity)
- B2694-121537
- 2,2'-piperazine-1,4-diylbis(6,7-dimethoxyquinazolin-4-amine)
- 2,2''-(1,4-Piperazinediyl)Bis[6,7-Dimethoxy-4-Quinazolinamine]
- 2,2'-(Piperazin-1,4-diyl)bis(6,7-dimethoxyquinazolin-4-amine)
- TERAZOSIN HYDROCHLORIDE DIHYDRATE IMPURITY E (EP IMPURITY)
- 2,2'-(1,4-Piperazinediyl)bis[6,7-dimethoxy-4-quinazolinamine]
- Prazosin EP Impurity E; Doxazosin EP Impurity H; Terazosin EP Impurity E
- 2,2'-(1,4-Piperazinediyl)bis[6,7-dimethoxy-4-quinazolinamine] (Terazosin Impurity)
- 2,2'-(1,4-Piperazinediyl)bis6,7-dimethoxy-4-quinazolinamine(Terazosin Impurity)
- 2-[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-6,7-dimethoxy-4-quinazolinylamine #
- 2-[4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-6,7-dimethoxy-quinazolin-4-amine
- 2-[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazinyl]-6,7-dimethoxyquinazoli ne-4-ylamine
- Doxazosin Mesilate Imp. H (EP); Prazosin Hydrochloride Imp. E (EP); Prazosin Imp. E (EP); Terazosin Hydrochloride Dihydrate Imp. E (EP); Terazosin Imp. E (EP); Terazosin USP Related Compound C; Terazosin USP RC C; 2,2'-(Piperazin-1,4-diyl)bis-(6,7-dimethoxyquinazolin-4-amine); 2,2'-(1,4-Piperazinediyl)bis[6,7-dimethoxy-4-quinazolinamine; Terazosin Related Compound C; Doxazosin Mesilate Impurity H; Prazosin Hydrochloride Impurity E; Terazosin Hydrochloride Dihydrate Impurity E; Doxazosin Impurity H; Prazosin Impurity E; Terazosin Impurity E
- Prazosin BP Impurity E; Terazosin EP Impurity E; 2,2?-(1,4-Piperazinediyl)bis[6,7-dimethoxy-4-quinazolinamine]